Methyl iodide → HCID 56834371、化合物
反応式
[Br:1][C:2]1[CH:3]=[CH:4][C:5]2[C:11]3[S:12][C:13]([C:15]([NH:17][C:18]4[CH:19]=[C:20]([CH:25]=[CH:26][C:27]=4[Cl:28])[C:21]([O:23][CH3:24])=[O:22])=[O:16])=[CH:14][C:10]=3[CH2:9][CH2:8][O:7][C:6]=2[CH:29]=1.[C:30]([O-])([O-])=O.[Cs+].[Cs+].CI>CN(C=O)C>[Br:1][C:2]1[CH:3]=[CH:4][C:5]2[C:11]3[S:12][C:13]([C:15]([N:17]([C:18]4[CH:19]=[C:20]([CH:25]=[CH:26][C:27]=4[Cl:28])[C:21]([O:23][CH3:24])=[O:22])[CH3:30])=[O:16])=[CH:14][C:10]=3[CH2:9][CH2:8][O:7][C:6]=2[CH:29]=1参加物
5
実験手順
To a solution of methyl 3-(8-bromo-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamido)-4-chlorobenzoate (32 g, 65 mmol) and Cs2CO3 (42.4 g, 130 mmol) in DMF (500 mL) was added CH3I (12 mL, 195 mmol). The reaction mixture was stirred at room temperature overnight. Then it was concentrated to remove the DMF, and water was added into the mixture. The resulting precipitate was filtrated, washed by water, and dried to give methyl 3-(8-bromo-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamido)-4-chlorobenzoate (31 g, 94%)1H NMR (CDCl3, 400 MHz): δ8.07-7.08 (m, 6H, ArH), 6.81 (s, 1H, ═CH), 4.22 (t, J=5.2 Hz, 2H, CH2), 3.94 (s, 3H, OCH3), 3.40 (s, 3H, NCH3), 3.01 (t, J=5.2 Hz, 2H, CH2)
後処理
- concentrationThen it was concentrated
- customto remove the DMF, and water
- additionwas added into the mixture
- filtrationThe resulting precipitate was filtrated
- washwashed by water
- customdried
出典と根拠
- ORDレコード
- ord-5bc1f96958b44fc8b659fb3c86a40f89
- 出典データセット
- uspto-grants-2015_11
- 特許番号
- US09175009B2
反応ノート
読み込み中…